Page 28 - Read Online

Xu et al. Radiation therapy in keloids treatment

Patient consent beta 1-induced fibrosis effects of IL-10 on dermal fibroblasts and
Not applicable. its potential therapeutics for the reduction of skin scarring. Arch
Dermatol Res 2013;305:341-52.
17. Walmsley GG, Maan ZN, Wong VW, Duscher D, Hu MS, Zielins ER,
Ethics approval Wearda T, Muhonen E, McArdle A, Tevlin R, Atashroo DA, Senarath-
Not applicable. Yapa K, Lorenz HP, Gurtner GC, Longaker MT. Scarless wound
healing: chasing the holy grail. Plast Reconstr Surg 2015;135:907-17.
18. Ud-Din S, Bowring A, Derbyshire B, Morris J, Bayat A. Identification
REFERENCES of steroid sensitive responders versus non-responders in the treatment
of keloid disease. Arch Dermatol Res 2013;305:423-32.
1. Bennett KG, Kung TA, Hayman JA, Brown DL. Treatment of keloids 19. Jumper N, Hodgkinson T, Arscott G, Har-Shai Y, Paus R, Bayat
with excision and adjuvant radiation: a single center experience and A. The Aldo-Keto Reductase AKR1B10 is up-regulated in keloid
review of the literature. Ann Plast Surg 2017;78:157-61. epidermis, implicating retinoic acid pathway dysregulation in the
2. Ogawa R, Hsu CK. Mechanobiological dysregulation of the epidermis pathogenesis of keloid disease. J Invest Dermatol 2016;136:1500-12.
and dermis in skin disorders and in degeneration. J Cell Mol Med 20. Li ZJ, Kim SM. The application of the starfish hatching enzyme for
2013;17:817-22. the improvement of scar and keloid based on the fibroblast-populated
3. Ha JM, Kim HS, Cho EB, Park GH, Park EJ, Kim KH, Kim LS, collagen lattice. Appl Biochem Biotechnol 2014;173:989-1002.
Kim KJ. Comparison of the effectiveness of nonablative fractional 21. Lee WJ, Choi IK, Lee JH, Kim YO, Yun CO. A novel three-
laser versus pulsed-dye laser in thyroidectomy scar prevention. Ann dimensional model system for keloid study: organotypic multicellular
Dermatol 2014;26:615-20. scar model. Wound Repair Regen 2013;21:155-65.
4. Rabello FB, Souza CD, Farina Junior JA. Update on hypertrophic scar 22. Arno AI, Gauglitz GG, Barret JP, Jeschke MG. Up-to-date approach
treatment. Clinics (Sao Paulo) 2014;69:565-73. to manage keloids and hypertrophic scars: a useful guide. Burns
5. Supp DM, Hahn JM, McFarland KL, Glaser K. Inhibition of 2014;40:1255-66.
hyaluronan synthase 2 reduces the abnormal migration rate of keloid 23. Shaarawy E, Hegazy RA, Abdel Hay RM. Intralesional botulinum
keratinocytes. J Burn Care Res 2014;35:84-92.
6. Ogawa R. Keloid and hypertrophic scars are the result of chronic toxin type A equally effective and better tolerated than intralesional
inflammation in the reticular dermis. Int J Mol Sci 2017;18:E606. steroid in the treatment of keloids: a randomized controlled trial. J
7. Andrews JP, Marttala J, Macarak E, Rosenbloom J, Uitto J. Keloids: Cosmet Dermatol 2015;14:161-6.
the paradigm of skin fibrosis - pathomechanisms and treatment. 24. Brewin MP, Lister TS. Prevention or treatment of hypertrophic burn
scarring: a review of when and how to treat with the pulsed dye laser.
Matrix Biol 2016;51:37-46.
8. van den Broek LJ, Limandjaja GC, Niessen FB, Gibbs S. Human Burns 2014;40:797-804.
hypertrophic and keloid scar models: principles, limitations and 25. Zhu Z, Ding J, Tredget EE. The molecular basis of hypertrophic scars.
future challenges from a tissue engineering perspective. Exp Dermatol Burns Trauma 2016;4:2.
2014;23:382-6. 26. Seo BF, Lee JY, Jung SN. Models of abnormal scarring. Biomed Res
9. Zonari A, Martins TM, Paula AC, Boeloni JN, Novikoff S, Marques Int 2013;2013:423147.
AP, Correlo VM, Reis RL, Goes AM. Polyhydroxybutyrate-co- 27. Hwang SH, Hwang K. Outcomes of surgical excision with pressure
hydroxyvalerate structures loaded with adipose stem cells promote therapy using magnets and identification of risk factors for recurrent
skin healing with reduced scarring. Acta Biomater 2015;17:170-81. keloids. Plast Reconstr Surg 2013;132:e666-7.
10. Hahn JM, Glaser K, McFarland KL, Aronow BJ, Boyce ST, Supp DM. 28. Enwerem-Bromson N, Abdel-Wahab M. Expanding global access to
Keloid-derived keratinocytes exhibit an abnormal gene expression radiotherapy: the IAEA perspective. Lancet Oncol 2015;16:1151-2.
profile consistent with a distinct causal role in keloid pathology. 29. Arno AI, Gauglitz GG, Barret JP, Jeschke MG. Up-to-date approach
Wound Repair Regen 2013;21:530-44. to manage keloids and hypertrophic scars: a useful guide. Burns
11. Ma X, Chen J, Xu B, Long X, Qin H, Zhao RC, Wang X. Keloid- 2014;40:1255-66.
derived keratinocytes acquire a fibroblast-like appearance and an 30. Shen J, Lian X, Sun Y, Wang X, Hu K, Hou X, Sun S, Yan J, Yu L,
enhanced invasive capacity in a hypoxic microenvironment in vitro. Sun X, Li W, Wang X, Guan Q, Pang T, Zhang F. Hypofractionated
Int J Mol Med 2015;35:1246-56. electron-beam radiation therapy for keloids: retrospective study of
12. Douaiher J, Succar J, Lancerotto L, Gurish MF, Orgill DP, Hamilton 568 cases with 834 lesions. J Radiat Res 2015;56:811-7.
MJ, Krilis SA, Stevens RL. Development of mast cells and importance 31. Basan M, Elgeti J, Hannezo E, Rappel WJ, Levine H. Alignment of
of their tryptase and chymase serine proteases in inflammation and cellular motility forces with tissue flow as a mechanism for efficient
wound healing. Adv Immunol 2014;122:211-52. wound healing. Proc Natl Acad Sci U S A 2013;110:2452-9.
13. Har-Shai Y, Sommer A, Gil T, Krausz J, Gal-Or N, Mettanes I, Lavi 32. Shah VV, Aldahan AS, Mlacker S, Alsaidan M, Samarkandy S, Nouri
I, Eyal N, Brizgalin L, Taran A, Har-Shai L, Elmalach I. Intralesional K. 5-fluorouracil in the treatment of keloids and hypertrophic scars:
cryosurgery for the treatment of basal cell carcinoma of the lower a comprehensive review of the literature. Dermatol Ther (Heidelb)
extremities in elderly subjects: a feasibility study. Int J Dermatol 2016;6:169-83.
2016;55:342-50. 33. Yamamori T, Ike S, Bo T, Sasagawa T, Sakai Y, Suzuki M, Yamamoto
14. Pakyari M, Farrokhi A, Maharlooei MK, Ghahary A. Critical role of K, Nagane M, Yasui H, Inanami O. Inhibition of the mitochondrial
transforming growth factor beta in different phases of wound healing. fission protein dynamin-related protein 1 (Drp1) impairs mitochondrial
Adv Wound Care (New Rochelle) 2013;2:215-24. fission and mitotic catastrophe after x-irradiation. Mol Biol Cell
15. Wang YW, Liou NH, Cherng JH, Chang SJ, Ma KH, Fu E, Liu JC, 2015;26:4607-17.
Dai NT. siRNA-targeting transforming growth factor-beta type I 34. Maier P, Hartmann L, Wenz F, Herskind C. Cellular pathways
receptor reduces wound scarring and extracellular matrix deposition in response to ionizing radiation and their targetability for tumor
of scar tissue. J Invest Dermatol 2014;134:2016-25. radiosensitization. Int J Mol Sci 2016;17:E102.
16. Shi JH, Guan H, Shi S, Cai WX, Bai XZ, Hu XL, Fang XB, Liu 35. Sun XJ, Wang Q, Guo B, Liu XY, Wang B. Identification of skin-
JQ, Tao K, Zhu XX, Tang CW, Hu DH. Protection against TGF- related lncRNAs as potential biomarkers that involved in Wnt
124 Plastic and Aesthetic Research ¦ Volume 4 ¦ July 28, 2017